Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PROMISE

Financiado

Cerrado

Preparing for RSV Immunisation and Surveillance in Europe

RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progress has been made in development of products for active and passive immunization against RS... ver más

30/04/2024

UEDIN

7M€

Presupuesto del proyecto: 7M€

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 25 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-04-30

IMI2-2020-22-01: Restricted Call to maximise impact...

I+D

Cerrada hace 4 años

0% 57% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

25 Participantes

UEDIN

746.63K€ | Lider

INETUM ESPAÑA

955.41K€ | Participante

JANSSEN PHARMACEUTICA NV

550.00K€ | Participante

VARSINAISSUOMEN HYVINVOINTIA...

126.91K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RESCEU REspiratory Syncytial virus Consortium in EUrope Sofia ref... 25M€ Cerrado

RSVTriVax Development of a trivalent epitope focused RSV vaccine to bo... 150K€ Cerrado

Vaccinesurvey Monitor population immunity against vaccine preventable dise... 1M€ Cerrado

INCENTIVE Indo European Consortium for Next Generation Influenza Vacci... 20M€ Cerrado

REACT Respiratory Host-Pathogen Interaction 8M€ Cerrado

VITAL Vaccines and Infectious Diseases in the Ageing PopuLation 12M€ Cerrado

Duración del proyecto: 35 meses Fecha Inicio: 2021-05-21
Fecha Fin: 2024-04-30

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 7M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progress has been made in development of products for active and passive immunization against RSV, with 19 products currently in clinical development. In 2017, we were funded by IMI to set up RESCEU project (Grant Agreement number 116019), which is the single largest consortium currently working on RSV and has addressed several of the key evidence gaps to inform the introduction of an RSV vaccine. However, new gaps in evidence have emerged and many key requirements for the introduction of a novel RSV vaccine into national immunisation programmes (not addressed within RESCEU) remain unmet. PROMISE’s vision is to seamlessly build on, exploit, and add value to the significant achievements of RESCEU to prepare for the imminent introduction of an RSV vaccine. Expanding the existing RESCEU network to include 5 new partners, PROMISE comprises of 5 distinct but inter-connected work packages (WPs). WP 1 will conduct epidemiological and cost-effectiveness analyses marshalling data from systematic reviews; national and regional disease registries; surveillance programmes and linked routine healthcare datasets. WP2 will foster a consensus and develop an operational plan for expanded coordinated RSV surveillance and reporting activities; post-licensure monitoring and evaluation of products for RSV immunization across Europe. WP3 will initiate new prospective studies to address key gaps in existing knowledge (RSV disease severity scores, asthma in school age children) and assemble biobanks for biomarker validation. WP4 will validate temporally and at mucosal level biomarkers that were identified in RESCEU adopting state of the art technologies. WPs 1-4 will develop high-quality, sustainable, robust data collection systems that link closely with public health/regulatory bodies/health care providers for informing policy and regulatory processes.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores